The effects of 1-alkylimidazoles on hepatic drug-metabolizing enzyme activity.
D000478:Alkylation; D000633:Aminopyrine N-Demethylase / Q000037:antagonists & inhibitors; D000814:Aniline Compounds; D000818:Animals; D001711:Biotransformation / Q000187:drug effects; D065607:Cytochrome P-450 Enzyme Inhibitors; D006591:Hexobarbital / Q000037:antagonists & inhibitors / Q000494:pharmacology; D007093:Imidazoles / Q000138:chemical synthesis / Q000494:pharmacology*; D007521:Isocitrate Dehydrogenase / Q000037:antagonists & inhibitors; D007700:Kinetics; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D008862:Microsomes, Liver / Q000201:enzymology*; D006899:Mixed Function Oxygenases / Q000037:antagonists & inhibitors; D051381:Rats; D012890:Sleep / Q000187:drug effects; D013053:Spectrophotometry; D013997:Time Factors
D000814:Aniline Compounds; D065607:Cytochrome P-450 Enzyme Inhibitors; D007093:Imidazoles; D006591:Hexobarbital; D006899:Mixed Function Oxygenases; D007521:Isocitrate Dehydrogenase; D000633:Aminopyrine N-Demethylase